Non-Current Liabilities
Long-Term Debt
Amgen Long-Term Debt increased by 3.8% to $51.89B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.9%, from $54.01B to $51.89B. Over 5 years (FY 2020 to FY 2025), Long-Term Debt shows an upward trend with a 8.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Higher levels indicate greater financial leverage, which can amplify returns but also increase financial risk and interest expense burdens.
Detailed definition
Long-term debt includes all interest-bearing financial obligations with a maturity date extending beyond one year. It is...
Peer comparison
Biotech firms often carry significant debt to fund long-term drug development; peers are compared based on debt-to-equity ratios.
Metric ID:
long_term_debtHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.46B | $33.29B | $33.22B | $36.01B | $35.71B | $37.16B | $37.35B | $60.76B | $59.38B | $59.04B | $63.17B | $60.06B | $57.12B | $56.85B | $56.55B | $54.01B | $53.76B | $52.43B | $50.01B | $51.89B |
| QoQ Change | — | +17.0% | -0.2% | +8.4% | -0.8% | +4.1% | +0.5% | +62.7% | -2.3% | -0.6% | +7.0% | -4.9% | -4.9% | -0.5% | -0.5% | -4.5% | -0.5% | -2.5% | -4.6% | +3.8% |
| YoY Change | — | — | — | — | +25.5% | +11.6% | +12.4% | +68.7% | +66.3% | +58.9% | +69.1% | -1.2% | -3.8% | -3.7% | -10.5% | -10.1% | -5.9% | -7.8% | -11.6% | -3.9% |
Range$28.46B – $63.17B
CAGR+13.5%
Avg YoY Growth+15.9%
Median YoY Growth-2.4%
Long-Term Debt at Other Companies
Frequently Asked Questions
- What is Amgen's long-term debt?
- Amgen (AMGN) reported long-term debt of $51.89B in Q1 2026.
- How has Amgen's long-term debt changed year-over-year?
- Amgen's long-term debt decreased by 3.9% year-over-year, from $54.01B to $51.89B.
- What is the long-term trend for Amgen's long-term debt?
- Over 5 years (2020 to 2025), Amgen's long-term debt has grown at a 8.7% compound annual growth rate (CAGR), from $32.9B to $50.01B.
- What does long-term debt mean?
- Debt obligations that are not due for repayment within the next year.